Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2020 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (135)	5/22/2020 9:54:23 PM
From: Arthur Radley	1 Recommendation Recommended By rkrw Respond to of 259

Bulba, After 8 weeks of cohabiting in a self-imposed stay at home with a woman I really love, the fact that it appears I’ve finally moved to the positive side for valuation of my portfolio you could have mentioned this accomplishment. You could simply put an asterisk to note my savvy stock picking has got its MoJo back..that until next Friday.

To: BulbaMan who wrote (135)	5/22/2020 9:55:21 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 259

Bulba, After 8 weeks of cohabiting in a self-imposed stay at home with a woman I really love, the fact that it appears I’ve finally moved to the positive side for valuation of my portfolio you could have mentioned this accomplishment. You could simply put an asterisk to note my savvy stock picking has got its MoJo back..that is until next Friday.

To: BulbaMan who wrote (135)	5/29/2020 11:54:20 PM
From: BulbaMan	Read Replies (1) \| Respond to of 259

5/29/2020 Contest update (Contest YTD is calculated from 1/3/2020 close.) The financial markets reacted to President Trump’s war of words with Twitter, China and the mayor of Minneapolis with just a mild hiccup. Nonetheless, for whatever reason, there was a bit of profit-taking in our smaller-cap biotechs. At Friday’s close, the Contest median was up 7.68% YTD (vs. up 10.97% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 13.84% YTD (vs. up 12.78% YTD a week ago), the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 11.01% YTD (vs. up 13.69% YTD a week ago), while the Nasdaq Composite Index (NCI) was up 5.20% YTD (vs. up 3.37% YTD a week ago). We have a new Contest leader! Blasted into first place by ADAP’s surge, FILO’s portfolio finished the week with a phenomenal 133.21% YTD gain. JBOG’s portfolio, up 101.51% YTD, fell to second place, while DEWDIL’s portfolio, up 63.95% YTD, jumped into third place with a boost from TARA. At Friday's close, 25 of the 42 Contest portfolios were in the green, with 17 beating the NBI and 18 still beating the SPSIBI. The 197 Contest stock picks have an average YTD gain of 23.79% with the YTD median at 2.47%. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.) Portfolio adjustments: ZFGN symbol change to LRMR witha 1-12 reverse split. (All corrections, especially adjustments for splits & mergers, greatly appreciated.) Stay safe and enjoy the final May weekend biotechies! Peace & good health, Bulba 5/29/20 Rank Name Profit/Loss 1 FILO 133,206 2 JBOG 101,508 3 DEWDIL 63,946 4 BIOSCI 58,972 5 YVR 52,514 6 IPOL 50,789 7 DOUGH 44,266 8 OLIVIER 39,958 9 BULBA 32,562 10 MASTER 29,688 Week's Top 5 Gainers Symbol 5/22/20 5/29/20 Wk.%chg. ADAP 5.770 11.070 91.85% ARPO 0.780 1.120 43.59% IDYA 6.990 9.790 40.06% MLND 2.000 2.660 33.00% NGEN.V 1.800 2.390 32.78% Week's Worst 5 Losers Symbol 5/22/20 5/29/20 Wk.%chg. NERV 14.280 3.710 -74.02% ARYC 0.012 0.008 -33.33% MDGS 3.020 2.140 -29.14% ARVN 44.040 33.270 -24.46% MGNX 25.370 19.240 -24.16%